Cargando…

The Use of Distinctive Monoclonal Antibodies in FMD VLP- and P1-Based Blocking ELISA for the Seromonitoring of Vaccinated Swine

The serum neutralization (SN) test has been regarded as the “gold standard” for seroconversion following foot-and-mouth disease virus (FMDV) vaccination, although a high-level biosafety laboratory is necessary. ELISA is one alternative, and its format is constantly being improved. For instance, stan...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Heng-Wei, Yang, Cheng-Yao, Lee, Ming-Chang, Chen, Shih-Ping, Chang, Hui-Wen, Cheng, Ivan-Chen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9368795/
https://www.ncbi.nlm.nih.gov/pubmed/35955678
http://dx.doi.org/10.3390/ijms23158542
_version_ 1784766251887755264
author Lee, Heng-Wei
Yang, Cheng-Yao
Lee, Ming-Chang
Chen, Shih-Ping
Chang, Hui-Wen
Cheng, Ivan-Chen
author_facet Lee, Heng-Wei
Yang, Cheng-Yao
Lee, Ming-Chang
Chen, Shih-Ping
Chang, Hui-Wen
Cheng, Ivan-Chen
author_sort Lee, Heng-Wei
collection PubMed
description The serum neutralization (SN) test has been regarded as the “gold standard” for seroconversion following foot-and-mouth disease virus (FMDV) vaccination, although a high-level biosafety laboratory is necessary. ELISA is one alternative, and its format is constantly being improved. For instance, standard polyclonal antisera have been replaced by monoclonal antibodies (MAbs) for catching and detecting antibodies, and inactive viruses have been replaced by virus-like particles (VLPs). To the best of current knowledge, however, no researchers have evaluated the performances of different MAbs as tracers. In previous studies, we successfully identified site 1 and site 2 MAbs Q10E and P11A. In this study, following the established screening platform, the VLPs of putative escape mutants from sites 1 to 5 were expressed and used to demonstrate that S11B is a site 3 MAb. Additionally, the vulnerability of VLPs prompted us to assess another diagnostic antigen: unprocessed polyprotein P1. Therefore, we established and evaluated the performance of blocking ELISA (bELISA) systems based on VLPs and P1, pairing them with Q10E, P11A, S11B, and the non-neutralizing TSG MAb as tracers. The results indicated that the VLP paired with S11B demonstrated the highest correlation with the SN titers (R(2) = 0.8071, n = 63). Excluding weakly positive serum samples (SN = 16–32, n = 14), the sensitivity and specificity were 95.65% and 96.15% (kappa = 0.92), respectively. Additionally, the P1 pairing with Q10E also demonstrated a high correlation (R(2) = 0.768). We also discovered that these four antibodies had steric effects on one another to varying degrees, despite recognizing distinct antigenic sites. This finding indicated that MAbs as tracers could not accurately detect specific antibodies, possibly because MAbs are bulky compared to a protomeric unit. However, our results still provide convincing support for the application of two pairs of bELISA systems: VLP:S11B-HRP and P1:Q10E-HRP.
format Online
Article
Text
id pubmed-9368795
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-93687952022-08-12 The Use of Distinctive Monoclonal Antibodies in FMD VLP- and P1-Based Blocking ELISA for the Seromonitoring of Vaccinated Swine Lee, Heng-Wei Yang, Cheng-Yao Lee, Ming-Chang Chen, Shih-Ping Chang, Hui-Wen Cheng, Ivan-Chen Int J Mol Sci Article The serum neutralization (SN) test has been regarded as the “gold standard” for seroconversion following foot-and-mouth disease virus (FMDV) vaccination, although a high-level biosafety laboratory is necessary. ELISA is one alternative, and its format is constantly being improved. For instance, standard polyclonal antisera have been replaced by monoclonal antibodies (MAbs) for catching and detecting antibodies, and inactive viruses have been replaced by virus-like particles (VLPs). To the best of current knowledge, however, no researchers have evaluated the performances of different MAbs as tracers. In previous studies, we successfully identified site 1 and site 2 MAbs Q10E and P11A. In this study, following the established screening platform, the VLPs of putative escape mutants from sites 1 to 5 were expressed and used to demonstrate that S11B is a site 3 MAb. Additionally, the vulnerability of VLPs prompted us to assess another diagnostic antigen: unprocessed polyprotein P1. Therefore, we established and evaluated the performance of blocking ELISA (bELISA) systems based on VLPs and P1, pairing them with Q10E, P11A, S11B, and the non-neutralizing TSG MAb as tracers. The results indicated that the VLP paired with S11B demonstrated the highest correlation with the SN titers (R(2) = 0.8071, n = 63). Excluding weakly positive serum samples (SN = 16–32, n = 14), the sensitivity and specificity were 95.65% and 96.15% (kappa = 0.92), respectively. Additionally, the P1 pairing with Q10E also demonstrated a high correlation (R(2) = 0.768). We also discovered that these four antibodies had steric effects on one another to varying degrees, despite recognizing distinct antigenic sites. This finding indicated that MAbs as tracers could not accurately detect specific antibodies, possibly because MAbs are bulky compared to a protomeric unit. However, our results still provide convincing support for the application of two pairs of bELISA systems: VLP:S11B-HRP and P1:Q10E-HRP. MDPI 2022-08-01 /pmc/articles/PMC9368795/ /pubmed/35955678 http://dx.doi.org/10.3390/ijms23158542 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Lee, Heng-Wei
Yang, Cheng-Yao
Lee, Ming-Chang
Chen, Shih-Ping
Chang, Hui-Wen
Cheng, Ivan-Chen
The Use of Distinctive Monoclonal Antibodies in FMD VLP- and P1-Based Blocking ELISA for the Seromonitoring of Vaccinated Swine
title The Use of Distinctive Monoclonal Antibodies in FMD VLP- and P1-Based Blocking ELISA for the Seromonitoring of Vaccinated Swine
title_full The Use of Distinctive Monoclonal Antibodies in FMD VLP- and P1-Based Blocking ELISA for the Seromonitoring of Vaccinated Swine
title_fullStr The Use of Distinctive Monoclonal Antibodies in FMD VLP- and P1-Based Blocking ELISA for the Seromonitoring of Vaccinated Swine
title_full_unstemmed The Use of Distinctive Monoclonal Antibodies in FMD VLP- and P1-Based Blocking ELISA for the Seromonitoring of Vaccinated Swine
title_short The Use of Distinctive Monoclonal Antibodies in FMD VLP- and P1-Based Blocking ELISA for the Seromonitoring of Vaccinated Swine
title_sort use of distinctive monoclonal antibodies in fmd vlp- and p1-based blocking elisa for the seromonitoring of vaccinated swine
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9368795/
https://www.ncbi.nlm.nih.gov/pubmed/35955678
http://dx.doi.org/10.3390/ijms23158542
work_keys_str_mv AT leehengwei theuseofdistinctivemonoclonalantibodiesinfmdvlpandp1basedblockingelisafortheseromonitoringofvaccinatedswine
AT yangchengyao theuseofdistinctivemonoclonalantibodiesinfmdvlpandp1basedblockingelisafortheseromonitoringofvaccinatedswine
AT leemingchang theuseofdistinctivemonoclonalantibodiesinfmdvlpandp1basedblockingelisafortheseromonitoringofvaccinatedswine
AT chenshihping theuseofdistinctivemonoclonalantibodiesinfmdvlpandp1basedblockingelisafortheseromonitoringofvaccinatedswine
AT changhuiwen theuseofdistinctivemonoclonalantibodiesinfmdvlpandp1basedblockingelisafortheseromonitoringofvaccinatedswine
AT chengivanchen theuseofdistinctivemonoclonalantibodiesinfmdvlpandp1basedblockingelisafortheseromonitoringofvaccinatedswine
AT leehengwei useofdistinctivemonoclonalantibodiesinfmdvlpandp1basedblockingelisafortheseromonitoringofvaccinatedswine
AT yangchengyao useofdistinctivemonoclonalantibodiesinfmdvlpandp1basedblockingelisafortheseromonitoringofvaccinatedswine
AT leemingchang useofdistinctivemonoclonalantibodiesinfmdvlpandp1basedblockingelisafortheseromonitoringofvaccinatedswine
AT chenshihping useofdistinctivemonoclonalantibodiesinfmdvlpandp1basedblockingelisafortheseromonitoringofvaccinatedswine
AT changhuiwen useofdistinctivemonoclonalantibodiesinfmdvlpandp1basedblockingelisafortheseromonitoringofvaccinatedswine
AT chengivanchen useofdistinctivemonoclonalantibodiesinfmdvlpandp1basedblockingelisafortheseromonitoringofvaccinatedswine